BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 241 filers reported holding BEAM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $163,900,029 | -26.8% | 6,814,970 | -2.8% | 0.00% | -20.0% |
Q2 2023 | $223,828,630 | +14.5% | 7,009,979 | +9.8% | 0.01% | 0.0% |
Q1 2023 | $195,523,734 | -20.3% | 6,385,491 | +1.8% | 0.01% | -28.6% |
Q4 2022 | $245,361,670 | -16.6% | 6,273,630 | +1.6% | 0.01% | -22.2% |
Q3 2022 | $294,153,000 | +44.8% | 6,174,471 | +17.7% | 0.01% | +50.0% |
Q2 2022 | $203,092,000 | -24.8% | 5,246,501 | +11.3% | 0.01% | 0.0% |
Q1 2022 | $269,999,000 | -27.9% | 4,712,010 | +0.3% | 0.01% | -25.0% |
Q4 2021 | $374,325,000 | -4.8% | 4,697,265 | +4.0% | 0.01% | -20.0% |
Q3 2021 | $392,998,000 | -11.1% | 4,516,700 | +31.5% | 0.01% | -9.1% |
Q2 2021 | $442,193,000 | +70.9% | 3,435,572 | +6.3% | 0.01% | +57.1% |
Q1 2021 | $258,802,000 | +12.6% | 3,233,410 | +14.8% | 0.01% | 0.0% |
Q4 2020 | $229,868,000 | +315.3% | 2,815,630 | +25.2% | 0.01% | +250.0% |
Q3 2020 | $55,355,000 | +69.6% | 2,248,373 | +92.9% | 0.00% | +100.0% |
Q2 2020 | $32,637,000 | +1830.0% | 1,165,620 | +1140.8% | 0.00% | – |
Q1 2020 | $1,691,000 | – | 93,942 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,346,934 | $56,443,763 | 54.70% |
HSG Holding Ltd | 796,089 | $19,145,940 | 2.05% |
Redmile Group, LLC | 1,469,725 | $35,346,886 | 1.68% |
ARK Investment Management | 8,783,891 | $211,252,590 | 1.62% |
Casdin Capital, LLC | 570,000 | $13,708,500 | 1.52% |
Deep Track Capital, LP | 1,015,641 | $24,426,166 | 0.94% |
Yiheng Capital Management, L.P. | 560,500 | $13,480,025 | 0.69% |
Temasek Holdings (Private) Ltd | 4,317,789 | $103,842,825 | 0.62% |
FARALLON CAPITAL MANAGEMENT LLC | 4,481,839 | $107,788,228 | 0.54% |
Alphabet Inc. | 321,604 | $7,734,576 | 0.50% |